pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
GIM-122
Solid Tumor
Georgiamune Inc
0
catalysts
Phase 2
GIM-531
Metastatic Melanoma
Georgiamune Inc
0
catalysts
Preclinical
GIVI-MPC
Duchenne Muscular Dystrophy
IPS Heart Inc
0
catalysts
GLIPIZIDE AND METFORMIN HCL
GLIPIZIDE AND METFORMIN HCL (GLIPIZIDE AND METFORMIN HCL)
HERITAGE
catalysts
← prev
page 88 of 231
next →
131
Pain
89
Neurology
1
0
GLIPIZIDE AND METFORMIN HYDROCHLORIDE
GLIPIZIDE AND METFORMIN HYDROCHLORIDE (GLIPIZIDE AND METFORMIN HYDROCHLORIDE)
TEVA PHARMS
0
catalysts
Phase 2
GLIX-1
High-Grade Glioma
Tetragon Biosciences Ltd
0
catalysts
Phase 2
GLK-221
Keratoconus
$GKOS
GLAUKOS Corp
0
catalysts
Phase 2
GLK-302
pilocarpine
Presbyopia
Muscarinic acetylcholine receptor M1
Muscarinic acetylcholine receptor M3
$GKOS
GLAUKOS Corp
0
catalysts
Phase 2
GLK-321
Demodex Blepharitis
$GKOS
GLAUKOS Corp
0
catalysts
Phase 2
GLK-401
Age Related Macular Degeneration
$GKOS
GLAUKOS Corp
0
catalysts
Phase 3
GLM-101
Congenital Disorder of Glycosylation Type I A
Glycomine Inc
0
catalysts
Preclinical
GLR-2007
Malignant Glioma
Gan & Lee Pharmaceuticals Co Ltd
0
catalysts
Phase 2
GLY-200
Type 2 Diabetes
Glyscend Inc
0
catalysts
GLYBURIDE AND METFORMIN HYDROCHLORIDE
GLYBURIDE AND METFORMIN HYDROCHLORIDE (GLYBURIDE AND METFORMIN HYDROCHLORIDE)
AUROBINDO PHARMA
0
catalysts
Preclinical
GM-0111
Oral Mucositis
GlycoMira Therapeutics Inc
0
catalysts
Phase 1
GM-60106
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
JD Bioscience Inc
0
catalysts
Phase 1
GMA-301
Pulmonary Arterial Hypertension
Gmax Biopharm LLC
0
catalysts
Phase 1
GNS-3545
Idiopathic Pulmonary Fibrosis
Genosco Inc
0
catalysts
Phase 1
GNSC-001
Osteoarthritis
Genascence Corp
0
catalysts
Phase 2
GNT-0003
Crigler-Najjar Syndrome
Genethon SA
0
catalysts
Preclinical
GNT-0008
Limb-Girdle Muscular Dystrophy
Atamyo Therapeutics SAS
0
catalysts
Phase 1
GNTI-122
Type 1 Diabetes (Juvenile Diabetes)
GentiBio Inc
0
catalysts
Preclinical
GNTbm-TKI
Neuroendocrine Tumors
Great Novel Therapeutics Biotech & Medicals Corp
0
catalysts
Phase 2
GO-2032c
Refractory Acute Myeloid Leukemia
Genus Oncology LLC
0
catalysts
GOLYTELY
GOLYTELY (POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE)
AZURITY
0
catalysts
GOZELLIX
GOZELLIX (GOZETOTIDE)
TELIX INNOVATIONS
0
catalysts
Preclinical
GP-119
Alzheimer's Disease
GliaPharm SA
0
catalysts
Phase 3
GP-2
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast…
Vascular endothelial growth factor A, long form
$GLSI
Greenwich LifeSciences, Inc.
0
catalysts
Phase 2
GP-531
Congestive Heart Failure (Heart Failure)
ViCardia Therapeutics Inc
0
catalysts
Preclinical
GPX-002
Type 1 Diabetes (Juvenile Diabetes)
$GNPX
Genprex, Inc.
0
catalysts
